Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts

Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts

Currently, the main cause of death worldwide is cardiovascular disease. These diseases
are peripheral arterial disease (PAD) and coronary heart disease (CHD), which develops as a
result of critical atherosclerotic narrowing of supplying arteries(1). The restoration of tissue
perfusion is very crucial in repair of ischemic limb and preventing failure in patients with
coronary heart disease (CHD). Currently, revascularization techniques have greatly advanced

Solution preview for the order on Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts

APA

1668 words